Sarmadi Mojgan, Ship Jonathan A
Department of Oral Medicine, Pathology, Oncology, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
Quintessence Int. 2004 Jan;35(1):39-48.
This article presents an unusual case of major recurrent aphthous stomatitis that was refractory to multiple topical and systemic immunosuppressive therapies. Ultimately, thalidomide was selected despite its well-recognized adverse potential, and was successful in producing remission of ulcers. Strict clinical protocols were followed for this therapy in collaboration with numerous medical providers. This case illustrates the ability of multiple oral health and medical providers to collaborate in the diagnosis, management, and follow-up of a patient with an oral vesiculoerosive disease.
本文介绍了一例罕见的复发性重型阿弗他口炎病例,该病例对多种局部和全身免疫抑制治疗均无效。最终,尽管沙利度胺有公认的不良潜在风险,但还是被选用,并成功使溃疡缓解。在与众多医疗服务提供者合作的过程中,严格遵循了该治疗的临床方案。本病例说明了多个口腔健康和医疗服务提供者在诊断、管理和随访患有口腔水疱糜烂性疾病的患者方面进行协作的能力。